| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.2 | 9e-11 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.27 | 1e-07 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-06 |